Lewis William's Form 4 filing
INSMED Inc (INSM) · filed Jan 8, 2026
- Accession no.
- 0001402051-26-000005
- Filed
- Jan 8, 2026
- Trade date
- Jan 6-8, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $1.68M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lewis WilliamCIK 0001402051 | Director, Officer (Chair and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Common Stock | SSaleDisposed | −4,096 | $173.33 | −$709,959.68 | 320,987 | Direct | |
| Jan 7, 2026 | Common Stock | SSaleDisposed | −2,357 | $175.07 | −$412,639.99 | 318,630 | Direct | |
| Jan 8, 2026 | Common Stock | SSaleDisposed | −3,223 | $174.17 | −$561,349.91 | 315,407 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.